265 related articles for article (PubMed ID: 8366923)
1. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
Luft BJ; Hafner R; Korzun AH; Leport C; Antoniskis D; Bosler EM; Bourland DD; Uttamchandani R; Fuhrer J; Jacobson J
N Engl J Med; 1993 Sep; 329(14):995-1000. PubMed ID: 8366923
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
[TBL] [Abstract][Full Text] [Related]
4. Treatment of toxoplasmic encephalitis with intravenous clindamycin.
Dannemann BR; Israelski DM; Remington JS
Arch Intern Med; 1988 Nov; 148(11):2477-82. PubMed ID: 3190380
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasmic encephalitis in patients with AIDS.
Israelski DM; Remington JS
Infect Dis Clin North Am; 1988 Jun; 2(2):429-45. PubMed ID: 3060527
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
Foppa CU; Bini T; Gregis G; Lazzarin A; Esposito R; Moroni M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):187-9. PubMed ID: 2060526
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of toxoplasmic encephalitis in AIDS patients.
Filice G; Carnevale G; Orsolini P; Soldini L; Meroni V; Comolli G; Carenzo L
J Chemother; 1989 Jul; 1(4 Suppl):949-50. PubMed ID: 16312718
[No Abstract] [Full Text] [Related]
9. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
Katlama C
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):189-91. PubMed ID: 2060527
[TBL] [Abstract][Full Text] [Related]
11. Issues in toxoplasmosis.
McCabe R; Chirurgi V
Infect Dis Clin North Am; 1993 Sep; 7(3):587-604. PubMed ID: 8254161
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
[TBL] [Abstract][Full Text] [Related]
13. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient].
Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F
Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
Dannemann BR; McCutchan JA; Israelski DM; Antoniskis D; Leport C; Luft BJ; Chiu J; Vildé JL; Nussbaum JN; Orellana M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):193-5. PubMed ID: 2060529
[TBL] [Abstract][Full Text] [Related]
15. Retinal findings and characteristics in AIDS patients with systemic Mycobacterium avium-intracellulare complex and toxoplasmic encephalitis.
Arevalo JF; Quiceno JI; García RF; McCutchan JA; Munguia D; Nelson JA; Freeman WR
Ophthalmic Surg Lasers; 1997 Jan; 28(1):50-4. PubMed ID: 9031305
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system toxoplasmosis in adult Ethiopians.
Amogne W; Teshager G; Zenebe G
Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
[TBL] [Abstract][Full Text] [Related]
17. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
Dannemann B; McCutchan JA; Israelski D; Antoniskis D; Leport C; Luft B; Nussbaum J; Clumeck N; Morlat P; Chiu J
Ann Intern Med; 1992 Jan; 116(1):33-43. PubMed ID: 1727093
[TBL] [Abstract][Full Text] [Related]
18. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
20. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
